AT 1001 provides significant improvements in several symptoms and outcomes for patients with coeliac disease

Source: Inpharma, Volume 1, Number 1587, 2007-05-12 , pp. 10-10(1)

Publisher: Adis International

Keywords: Alba-Therapeutics-Corporation; AT-1001, therapeutic use; Coeliac-disease, treatment; Research-and-development; Trial-result-clinical

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers